AA

Ala Alenazi

VC & Growth @ Kinnevik | techbio investments | molecular genetics PhD

London, England

Invests in

Stages:

Sectors:

Medical Devices

Health & Hospital Services

Locations:

Min Investment:
$100,000.00
Max Investment:
$700,000.00
Target Investment:
$400,000.00

Skills

Education

Doctor of Philosophy (Ph.D.)
University of Cambridge
Master's degree
Imperial College London
Master's Research Project
UCL Cancer Institute
Leading with Finance
Harvard Business School Online
(2020)

Work Experience

2024

Investment Manager
2024
Investing in bio + ai Portfolio: Recursion (Nasdaq: RXRX), Enveda Biosciences

2022 - 2023

Board Observer
2022 - 2023

2021 - 2023

Principal, Life Fund
2022 - 2023
Investments: Acurable, Tailor Bio, Kuano, NunaBio, Panakeia, Neuronostics and Aparito (2024, exit to Eli Lilly)
Associate, Life Fund
2021 - 2022
Investments: Novai, Stablepharma, MedAll, ExSeed, Qureight, Veratrak, AMLo Biosciences and NebuFlow Ascension Life Fund is an EIS fund that invests in UK-based Seed+/Series A techbio companies.

2022 - 2023

Expert Evaluator & Panel (Biotech)
2022 - 2023

2022 - 2023

Board Observer
2022 - 2023

2023 - 2023

Board Member
2023 - 2023

Babraham Bioscience Technologies Ltd

2021 - 2023

Expert - Accelerate@Babraham
2021 - 2023

AMLo Biosciences

2022 - 2023

Board Observer
2022 - 2023

2021 - 2023

Healthcare Mentor
2021 - 2023

2022 - 2023

Judge - Libra Programme 2.0
2022 - 2023